These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6744856)

  • 1. Pharmacokinetics of different doses of norethisterone oenanthate.
    Fotherby K; Hamawi A; Howard G; Bye PG; Elder M
    Contraception; 1984 Apr; 29(4):325-33. PubMed ID: 6744856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
    Joshi JV; Hazari KT; Shah RS; Chadha UC; Chitlange S; Gokral JS; Arolkar SG
    Steroids; 1989 Jun; 53(6):751-61. PubMed ID: 2815152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
    Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
    Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different doses of norethisterone on ovarian function, serum sex hormone binding globulin and high density lipoprotein-cholesterol.
    Song S; Chen JK; Lu CH; Yang PJ; Yang QY; Fan BC; He ML; Gui YL; Li LM; Fotherby K
    Contraception; 1993 Jun; 47(6):527-37. PubMed ID: 8334889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of norethisterone, estradiol and progesterone after administration of norethisterone oenanthate at different sites: a cross-over study.
    Virutamasen P; Dhanapas S; Leepipatpaiboon S
    Asia Oceania J Obstet Gynaecol; 1987 Mar; 13(1):49-53. PubMed ID: 3593083
    [No Abstract]   [Full Text] [Related]  

  • 6. Return of ovulation and fertility in women using norethisterone oenanthate.
    Fotherby K; Yong-En S; Howard G; Elder MG; Muggeridge J
    Contraception; 1984 May; 29(5):447-55. PubMed ID: 6744861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of norethisterone in humans.
    Shi YE; He CH; Gu J; Fotherby K
    Contraception; 1987 May; 35(5):465-75. PubMed ID: 3621943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood hormone levels in egyptian women on norethisterone oenanthate.
    Saleh FM; Sallam HN; Abdel-Rahman H; Souka AR; El-Sahwi SY; Toppozada HK
    Contraception; 1983 Jul; 28(1):41-51. PubMed ID: 6414760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norethisterone levels in maternal serum and milk after intramuscular injection of norethisterone oenanthate as a contraceptive.
    Fotherby K; Towobola O; Muggeridge J; Elder MG
    Contraception; 1983 Nov; 28(5):405-11. PubMed ID: 6673900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
    Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
    Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.
    Meng YX; Virutamasen P
    Contraception; 1991 Jul; 44(1):73-82. PubMed ID: 1893702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
    Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
    Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
    Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of norethisterone capsules on the pituitary-ovarian axis.
    Nuttall ID; Elstein M; Fahmy DR
    Contraception; 1982 Jan; 25(1):51-7. PubMed ID: 6800692
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X.
    Howard G; Myatt L; Elder MG
    Br J Obstet Gynaecol; 1977 Aug; 84(8):618-21. PubMed ID: 889752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of norethisterone after single and multiple injections of norethisterone oenanthate.
    Fotherby K; Howard G; Shrimanker K; Elder M; Bye PG
    Contraception; 1978 Jul; 18(1):1-6. PubMed ID: 679682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.
    McEwan JA; Griffin M
    Contraception; 1991 Dec; 44(6):639-48. PubMed ID: 1773620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a low-dose monthly injectable contraceptive system: I. Choice of compounds, dose and administration route.
    Garza-Flores J; Diaz-Sanchez V; Jimenez-Thomas S; Rudel HW
    Contraception; 1984 Oct; 30(4):371-9. PubMed ID: 6509988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New long-acting injectable microcapsule contraceptive system.
    Beck LR; Cowsar DR; Lewis DH; Gibson JW; Flowers CE
    Am J Obstet Gynecol; 1979 Oct; 135(3):419-26. PubMed ID: 114054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
    McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
    Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.